BioCentury
ARTICLE | Financial News

IVGN meets Street EPS

October 25, 2001 7:00 AM UTC

Reagent tool company Invitrogen (IVGN) reported third quarter EPS of $0.42, meeting the Street estimate. Revenues for the third quarter were $156 million, up 11% from the $141 million pro forma figure...